BMY
Price
$46.26
Change
+$0.32 (+0.70%)
Updated
Nov 21, 04:59 PM (EDT)
Capitalization
93.52B
76 days until earnings call
Intraday BUY SELL Signals
OGN
Price
$7.21
Change
+$0.08 (+1.12%)
Updated
Nov 21, 04:59 PM (EDT)
Capitalization
1.85B
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMY vs OGN

Header iconBMY vs OGN Comparison
Open Charts BMY vs OGNBanner chart's image
Bristol-Myers Squibb
Price$46.26
Change+$0.32 (+0.70%)
Volume$106.3K
Capitalization93.52B
Organon & Co
Price$7.21
Change+$0.08 (+1.12%)
Volume$107.11K
Capitalization1.85B
BMY vs OGN Comparison Chart in %
BMY
Daily Signal:
Gain/Loss:
OGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BMY vs. OGN commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a Hold and OGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (BMY: $45.94 vs. OGN: $7.13)
Brand notoriety: BMY: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 75% vs. OGN: 87%
Market capitalization -- BMY: $93.52B vs. OGN: $1.85B
BMY [@Pharmaceuticals: Major] is valued at $93.52B. OGN’s [@Pharmaceuticals: Major] market capitalization is $1.85B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $933.76B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $99.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 2 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • BMY’s FA Score: 2 green, 3 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, BMY is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 4 TA indicator(s) are bullish while OGN’s TA Score has 5 bullish TA indicator(s).

  • BMY’s TA Score: 4 bullish, 6 bearish.
  • OGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OGN is a better buy in the short-term than BMY.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а -5.53% price change this week, while OGN (@Pharmaceuticals: Major) price change was -6.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.65%. For the same industry, the average monthly price growth was +2.17%, and the average quarterly price growth was +18.77%.

Reported Earning Dates

BMY is expected to report earnings on Feb 05, 2026.

OGN is expected to report earnings on Feb 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+0.65% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMY($93.5B) has a higher market cap than OGN($1.85B). BMY has higher P/E ratio than OGN: BMY (15.47) vs OGN (3.73). BMY YTD gains are higher at: -14.739 vs. OGN (-50.984). BMY has higher annual earnings (EBITDA): 14.9B vs. OGN (1.56B). OGN has less debt than BMY: OGN (8.9B) vs BMY (51B). BMY has higher revenues than OGN: BMY (48B) vs OGN (6.3B).
BMYOGNBMY / OGN
Capitalization93.5B1.85B5,043%
EBITDA14.9B1.56B956%
Gain YTD-14.739-50.98429%
P/E Ratio15.473.73414%
Revenue48B6.3B762%
Total Cash16.5BN/A-
Total Debt51B8.9B573%
FUNDAMENTALS RATINGS
BMY: Fundamental Ratings
BMY
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
27
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
34

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMYOGN
RSI
ODDS (%)
Bearish Trend 2 days ago
39%
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 4 days ago
52%
Bullish Trend 4 days ago
68%
Declines
ODDS (%)
Bearish Trend 8 days ago
54%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BMY
Daily Signal:
Gain/Loss:
OGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GCOR41.690.07
+0.16%
Goldman Sachs Access US Aggregate Bd ETF
PULS49.74N/A
N/A
PGIM Ultra Short Bond ETF
TJUL29.23-0.06
-0.21%
Innovator Eq Defnd Protd ETF2 Yr-Jul2027
CANQ29.79-0.33
-1.10%
Calamos Nasdaq® Equity & Income ETF
URAA30.83-4.36
-12.39%
DIREXION DAILY URANIUM INDUSTRY BULL 2X SHARES URAA